PROLACTIN STIMULATION BY INTRAVENOUS LABETALOL IS MEDIATED INSIDE THE CENTRAL NERVOUS-SYSTEM

被引：15

作者：

BARBIERI, C ^{[1
]}

LAROVERE, MT ^{[1
]}

MARIOTTI, G ^{[1
]}

FERRARI, C ^{[1
]}

CALDARA, R ^{[1
]}

机构：

[1] UNIV MILAN,MED CLIN 6,I-20133 MILAN,ITALY

来源：

CLINICAL ENDOCRINOLOGY | 1982年 / 16卷 / 06期

关键词：

D O I：

10.1111/j.1365-2265.1982.tb03178.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：615 / 619

页数：5

共 14 条

[1] METABOLIC EFFECTS OF PRAZOSIN [J].

BARBIERI, C ;

CALDARA, R ;

FERRARI, C ;

DALBO, GA ;

PARACCHI, A ;

ROMUSSI, M ;

CURTARELLI, G .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :313-316

[2] ENDOCRINE AND METABOLIC EFFECTS OF LABETALOL IN MAN [J].

BARBIERI, C ;

FERRARI, C ;

CALDARA, R ;

CROSSIGNANI, RM ;

BERTAZZONI, A .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (05) :986-991

[3]

BARBIERI C, 1980, J PHARMACOL EXP THER, V214, P433

[4] LABETALOL - REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN HYPERTENSION [J].

BROGDEN, RN ;

HEEL, RC ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1978, 15 (04) :251-270

[5]

CLEMENS JA, 1980, FED PROC, V39, P2588

[6] PROLACTIN-RELEASE BY INTRAVENOUS CIMETIDINE IN MAN - EVIDENCE FOR A SUPRAPITUITARY LOCUS OF ACTION [J].

FERRARI, C ;

CALDARA, R ;

BARBIERI, C ;

CAMBIELLI, M ;

BIERTI, L ;

ROMUSSI, M .

CLINICAL ENDOCRINOLOGY, 1979, 11 (06) :619-623

[7] LOSS OF CENTRAL NERVOUS-SYSTEM COMPONENT OF DOPAMINERGIC INHIBITION OF PROLACTIN SECRETION IN PATIENTS WITH PROLACTIN-SECRETING PITUITARY TUMORS [J].

FINE, SA ;

FROHMAN, LA .

JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (04) :973-980

[8]

HORROBIN DF, 1977, HYPERTENSIONS PHYSIO, P391

[9]

MARTIN LE, 1976, BRIT J CLIN PHARMACO, V3, P695

[10] LEVODOPA AND DECARBOXYLASE INHIBITORS - REVIEW OF THEIR CLINICAL PHARMACOLOGY AND USE IN TREATMENT OF PARKINSONISM [J].

PINDER, RM ;

BROGDEN, RN ;

SAWYER, PR ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1976, 11 (05) :329-377

← 1 2 →